Selected research
Industry Research
Pharmaceutical Outsourcing Analytical Testing Industry Research Report 2026
Market perspective
The global Pharmaceutical Outsourcing Analytical Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmaceutical Outsourcing Analytical Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceutical Outsourcing Analytical Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceutical Outsourcing Analytical Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceutical Outsourcing Analytical Testing include Merck, Recro Gainesville, Recipharm, Quotient Sciences, Metrics Contract Services, Frontida Biopharm, Frontage, ENCO Pharmaceutical Development and Catalent, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmaceutical Outsourcing Analytical Testing market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical Outsourcing Analytical Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Outsourcing Analytical Testing Market by Company
Merck
Recro Gainesville
Recipharm
Quotient Sciences
Metrics Contract Services
Frontida Biopharm
Frontage
ENCO Pharmaceutical Development
Catalent
Aztech Sciences
Ascendia Pharmaceuticals
ARL Bio Pharma
Alcami
Pharmaceutical Outsourcing Analytical Testing Segment by Type
Stability Testing
Bioanalytical Testing
Method Development & Validation
Others
Pharmaceutical Outsourcing Analytical Testing Segment by Application
Small & Medium Enterprise
Large Enterprise
Pharmaceutical Outsourcing Analytical Testing Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Outsourcing Analytical Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Outsourcing Analytical Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Outsourcing Analytical Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmaceutical Outsourcing Analytical Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stability Testing
- Bioanalytical Testing
- Method Development & Validation
- Others
Applications
- Small & Medium Enterprise
- Large Enterprise
Companies covered
- Merck
- Recro Gainesville
- Recipharm
- Quotient Sciences
- Metrics Contract Services
- Frontida Biopharm
- Frontage
- ENCO Pharmaceutical Development
- Catalent
- Aztech Sciences
- Ascendia Pharmaceuticals
- ARL Bio Pharma
- Alcami
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceutical Outsourcing Analytical Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Stability Testing
- 2.2.3 Bioanalytical Testing
- 2.2.4 Method Development & Validation
- 2.2.5 Others
- 2.3 Pharmaceutical Outsourcing Analytical Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Small & Medium Enterprise
- 2.3.3 Large Enterprise
- 2.4 Assumptions and Limitations
3 Pharmaceutical Outsourcing Analytical Testing Breakdown Data by Type
- 3.1 Global Pharmaceutical Outsourcing Analytical Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmaceutical Outsourcing Analytical Testing Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical Outsourcing Analytical Testing Breakdown Data by Application
- 4.1 Global Pharmaceutical Outsourcing Analytical Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmaceutical Outsourcing Analytical Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmaceutical Outsourcing Analytical Testing Market Perspective (2021-2032)
- 5.2 Global Pharmaceutical Outsourcing Analytical Testing Growth Trends by Region
- 5.2.1 Global Pharmaceutical Outsourcing Analytical Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmaceutical Outsourcing Analytical Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmaceutical Outsourcing Analytical Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmaceutical Outsourcing Analytical Testing Market Dynamics
- 5.3.1 Pharmaceutical Outsourcing Analytical Testing Industry Trends
- 5.3.2 Pharmaceutical Outsourcing Analytical Testing Market Drivers
- 5.3.3 Pharmaceutical Outsourcing Analytical Testing Market Challenges
- 5.3.4 Pharmaceutical Outsourcing Analytical Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmaceutical Outsourcing Analytical Testing Players by Revenue
- 6.1.1 Global Top Pharmaceutical Outsourcing Analytical Testing Players by Revenue (2021-2026)
- 6.1.2 Global Pharmaceutical Outsourcing Analytical Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmaceutical Outsourcing Analytical Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmaceutical Outsourcing Analytical Testing Head Office and Area Served
- 6.4 Global Pharmaceutical Outsourcing Analytical Testing Players, Product Type & Application
- 6.5 Global Pharmaceutical Outsourcing Analytical Testing Manufacturers Established Date
- 6.6 Global Pharmaceutical Outsourcing Analytical Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmaceutical Outsourcing Analytical Testing Market Size (2021-2032)
- 7.2 North America Pharmaceutical Outsourcing Analytical Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmaceutical Outsourcing Analytical Testing Market Size by Country (2021-2026)
- 7.4 North America Pharmaceutical Outsourcing Analytical Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmaceutical Outsourcing Analytical Testing Market Size (2021-2032)
- 8.2 Europe Pharmaceutical Outsourcing Analytical Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmaceutical Outsourcing Analytical Testing Market Size by Country (2021-2026)
- 8.4 Europe Pharmaceutical Outsourcing Analytical Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Outsourcing Analytical Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmaceutical Outsourcing Analytical Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmaceutical Outsourcing Analytical Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmaceutical Outsourcing Analytical Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmaceutical Outsourcing Analytical Testing Market Size (2021-2032)
- 10.2 South America Pharmaceutical Outsourcing Analytical Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmaceutical Outsourcing Analytical Testing Market Size by Country (2021-2026)
- 10.4 South America Pharmaceutical Outsourcing Analytical Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Outsourcing Analytical Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmaceutical Outsourcing Analytical Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmaceutical Outsourcing Analytical Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmaceutical Outsourcing Analytical Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Merck
- 12.1.1 Merck Company Information
- 12.1.2 Merck Business Overview
- 12.1.3 Merck Revenue in Pharmaceutical Outsourcing Analytical Testing Business (2021-2026)
- 12.1.4 Merck Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 12.1.5 Merck Recent Developments
- 12.2 Recro Gainesville
- 12.2.1 Recro Gainesville Company Information
- 12.2.2 Recro Gainesville Business Overview
- 12.2.3 Recro Gainesville Revenue in Pharmaceutical Outsourcing Analytical Testing Business (2021-2026)
- 12.2.4 Recro Gainesville Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 12.2.5 Recro Gainesville Recent Developments
- 12.3 Recipharm
- 12.3.1 Recipharm Company Information
- 12.3.2 Recipharm Business Overview
- 12.3.3 Recipharm Revenue in Pharmaceutical Outsourcing Analytical Testing Business (2021-2026)
- 12.3.4 Recipharm Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 12.3.5 Recipharm Recent Developments
- 12.4 Quotient Sciences
- 12.4.1 Quotient Sciences Company Information
- 12.4.2 Quotient Sciences Business Overview
- 12.4.3 Quotient Sciences Revenue in Pharmaceutical Outsourcing Analytical Testing Business (2021-2026)
- 12.4.4 Quotient Sciences Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 12.4.5 Quotient Sciences Recent Developments
- 12.5 Metrics Contract Services
- 12.5.1 Metrics Contract Services Company Information
- 12.5.2 Metrics Contract Services Business Overview
- 12.5.3 Metrics Contract Services Revenue in Pharmaceutical Outsourcing Analytical Testing Business (2021-2026)
- 12.5.4 Metrics Contract Services Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 12.5.5 Metrics Contract Services Recent Developments
- 12.6 Frontida Biopharm
- 12.6.1 Frontida Biopharm Company Information
- 12.6.2 Frontida Biopharm Business Overview
- 12.6.3 Frontida Biopharm Revenue in Pharmaceutical Outsourcing Analytical Testing Business (2021-2026)
- 12.6.4 Frontida Biopharm Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 12.6.5 Frontida Biopharm Recent Developments
- 12.7 Frontage
- 12.7.1 Frontage Company Information
- 12.7.2 Frontage Business Overview
- 12.7.3 Frontage Revenue in Pharmaceutical Outsourcing Analytical Testing Business (2021-2026)
- 12.7.4 Frontage Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 12.7.5 Frontage Recent Developments
- 12.8 ENCO Pharmaceutical Development
- 12.8.1 ENCO Pharmaceutical Development Company Information
- 12.8.2 ENCO Pharmaceutical Development Business Overview
- 12.8.3 ENCO Pharmaceutical Development Revenue in Pharmaceutical Outsourcing Analytical Testing Business (2021-2026)
- 12.8.4 ENCO Pharmaceutical Development Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 12.8.5 ENCO Pharmaceutical Development Recent Developments
- 12.9 Catalent
- 12.9.1 Catalent Company Information
- 12.9.2 Catalent Business Overview
- 12.9.3 Catalent Revenue in Pharmaceutical Outsourcing Analytical Testing Business (2021-2026)
- 12.9.4 Catalent Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 12.9.5 Catalent Recent Developments
- 12.10 Aztech Sciences
- 12.10.1 Aztech Sciences Company Information
- 12.10.2 Aztech Sciences Business Overview
- 12.10.3 Aztech Sciences Revenue in Pharmaceutical Outsourcing Analytical Testing Business (2021-2026)
- 12.10.4 Aztech Sciences Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 12.10.5 Aztech Sciences Recent Developments
- 12.11 Ascendia Pharmaceuticals
- 12.11.1 Ascendia Pharmaceuticals Company Information
- 12.11.2 Ascendia Pharmaceuticals Business Overview
- 12.11.3 Ascendia Pharmaceuticals Revenue in Pharmaceutical Outsourcing Analytical Testing Business (2021-2026)
- 12.11.4 Ascendia Pharmaceuticals Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 12.11.5 Ascendia Pharmaceuticals Recent Developments
- 12.12 ARL Bio Pharma
- 12.12.1 ARL Bio Pharma Company Information
- 12.12.2 ARL Bio Pharma Business Overview
- 12.12.3 ARL Bio Pharma Revenue in Pharmaceutical Outsourcing Analytical Testing Business (2021-2026)
- 12.12.4 ARL Bio Pharma Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 12.12.5 ARL Bio Pharma Recent Developments
- 12.13 Alcami
- 12.13.1 Alcami Company Information
- 12.13.2 Alcami Business Overview
- 12.13.3 Alcami Revenue in Pharmaceutical Outsourcing Analytical Testing Business (2021-2026)
- 12.13.4 Alcami Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 12.13.5 Alcami Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst